Table 3.
Percentage of gal-1, gal-3, pSTAT3 and pSTAT5 in JAK2 positive and JAK2 negative patients.
| JAK2 positive n=56 | JAK2 negative n=24 | |
|---|---|---|
| Galectin-1, %*, mean (SD) | 8.50 (4.04) | 7.36 (3.58) |
| Minimum-maximum (CI) | 1.12-20.32 (7.41-9.59) | 1.48-14.56 (5.82-8.91) |
| Galectin-3. %*. mean (SD) | 8.93 (5.34) | 7.04 (5.18) |
| Minimum-maximum (CI) | 0.56-23.50 (7.49-10.37) | 0.55-18.69 (4.80-9.28) |
| pSTAT3. %#. mean (SD) | 5.53 (2.80) | 4.18 (1.97) |
| Minimum-maximum (CI) | 1.02-14.67 (4.77-6.29) | 1.12-8.91 (3.33-5.03) |
| pSTAT5. %#. mean (SD) | 4.22 (3.48) | 3.04 (1.60) |
| Minimum-maximum (CI) | 0.26-13.71 (3.02-5.41) | 0.90-6.47 (2.27-3.81) |
| MVD. 1 mm2. mean (SD) | 52.77 (30.58) | 49.01 (25.98) |
| Minimum-maximum (CI) | 3.60-122.40 (44.72-63.18) | 17.20-111.20 (40.64-65.24) |
*
calculated as percentage positive area of total tissue area.
#
calculated as percentage positive nuclei of total nuclei count.